Medigene AG MDGEF:OTCPK

*Data is delayed | Exchange | USD
Last | 03/28/24 EDT
2.43UNCH (UNCH)
52 week range
1.50 - 2.84
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.43
  • 52 Week High2.84
  • 52 Week High Date03/25/24
  • 52 Week Low1.50
  • 52 Week Low Date12/28/23

Key Stats

  • Market Cap43.11M
  • Shares Out25.87M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change62

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.43
  • 52 Week High2.84
  • 52 Week High Date03/25/24
  • 52 Week Low1.50
  • 52 Week Low Date12/28/23
  • Market Cap43.11M
  • Shares Out25.87M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change62

RATIOS/PROFITABILITY

  • EPS (TTM)-0.69
  • P/E (TTM)-3.51
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/15/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Medigene AG

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Medigene AG is a Germany-based biotechnology company that develops treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. The Company focuses on the development of personalized T cell-based immunotherapies. It develops three platforms: T-cell receptor (TCR)-modified T cells for adoptive T-cell therapy as treatments for patients with tumor burdens; Dendritic cell (DC) vaccines for the treatment of low tumor...
Address
Lochhamer Strasse 11
Planegg
82152
Germany